Correlation
The correlation between ALTO and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
ALTO vs. PFE
Compare and contrast key facts about Alto Ingredients, Inc. (ALTO) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALTO or PFE.
Performance
ALTO vs. PFE - Performance Comparison
Loading data...
Key characteristics
ALTO:
-0.51
PFE:
-0.46
ALTO:
-0.35
PFE:
-0.52
ALTO:
0.95
PFE:
0.94
ALTO:
-0.38
PFE:
-0.19
ALTO:
-1.38
PFE:
-0.80
ALTO:
27.33%
PFE:
14.30%
ALTO:
72.31%
PFE:
24.17%
ALTO:
-99.99%
PFE:
-58.96%
ALTO:
-99.98%
PFE:
-54.50%
Fundamentals
ALTO:
$71.95M
PFE:
$133.32B
ALTO:
-$0.81
PFE:
$1.38
ALTO:
0.08
PFE:
2.13
ALTO:
0.34
PFE:
1.48
ALTO:
$951.17M
PFE:
$62.46B
ALTO:
$6.98M
PFE:
$42.09B
ALTO:
-$24.63M
PFE:
$16.71B
Returns By Period
In the year-to-date period, ALTO achieves a -40.51% return, which is significantly lower than PFE's -8.28% return. Over the past 10 years, ALTO has underperformed PFE with an annualized return of -21.89%, while PFE has yielded a comparatively higher 0.81% annualized return.
ALTO
-40.51%
2.91%
-36.00%
-36.87%
-40.70%
6.83%
-21.89%
PFE
-8.28%
-1.93%
-7.16%
-11.13%
-19.73%
-4.00%
0.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALTO vs. PFE — Risk-Adjusted Performance Rank
ALTO
PFE
ALTO vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Alto Ingredients, Inc. (ALTO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ALTO vs. PFE - Dividend Comparison
ALTO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.24%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALTO Alto Ingredients, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 7.24% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
ALTO vs. PFE - Drawdown Comparison
The maximum ALTO drawdown since its inception was -99.99%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for ALTO and PFE.
Loading data...
Volatility
ALTO vs. PFE - Volatility Comparison
Alto Ingredients, Inc. (ALTO) has a higher volatility of 23.12% compared to Pfizer Inc. (PFE) at 9.18%. This indicates that ALTO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ALTO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Alto Ingredients, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALTO vs. PFE - Profitability Comparison
ALTO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Alto Ingredients, Inc. reported a gross profit of -1.81M and revenue of 226.54M. Therefore, the gross margin over that period was -0.8%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
ALTO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Alto Ingredients, Inc. reported an operating income of -9.00M and revenue of 226.54M, resulting in an operating margin of -4.0%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
ALTO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Alto Ingredients, Inc. reported a net income of -11.68M and revenue of 226.54M, resulting in a net margin of -5.2%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.